MAPT and Alzheimer disease: It is well established that diabetes and AD share several pathological features, including impaired insulin signaling, dyslipidemia, decreased levels of choline acetyltransferase, increased production of AGEs and inflammatory mediators, as well as the accumulation of Aβ peptides and tau proteins [26].